002019 logo

Yifan Pharmaceutical Co., Ltd. Stock Price

SZSE:002019 Community·CN¥12.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

002019 Share Price Performance

CN¥0
-11.10 (-100.00%)
CN¥0
-11.10 (-100.00%)
Price CN¥0

002019 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and slightly overvalued.

2 Risks
2 Rewards

Yifan Pharmaceutical Co., Ltd. Key Details

CN¥5.2b

Revenue

CN¥2.8b

Cost of Revenue

CN¥2.4b

Gross Profit

CN¥2.0b

Other Expenses

CN¥407.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 24, 2026
0.39
45.74%
7.80%
28.4%
View Full Analysis

About 002019

Founded
2000
Employees
4098
CEO
Xian Feng Cheng
WebsiteView website
www.yifanyy.com

Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products, raw materials, and polymer materials in Southeast Asia, Europe and North America, Singapore, South Korea, Italy, China, Germany, and the United States. It offers Chinese patent medicines, chemical medicines and biological medicines; and vitamin products, including vitamin B5 and original B5. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016. Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is headquartered in Hangzhou, China.

Recent 002019 News & Updates

Recent updates

No updates